Dr. Brooks Gross is a Program Director in the Division of Translational Research at the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Gross manages a portfolio of NINDS and BRAIN Initiative translational device projects in the areas of neurotraumatic injuries, cognition, and neurorehabilitation technologies. Dr. Gross also co-leads the SPARC HORNET Initiative. Dr. Gross received his B.S. in Neuroscience from the University of Florida, M.S.E. in Biomedical Engineering from the University of Michigan, and Ph.D. in Systems Engineering from Oakland University. His dissertation research focused on both artificial neural networks to study chemical diffusion in the brain and the development of novel capacitance-based biosensors. Before joining the NIH, Dr. Gross spent 10-plus years leading research and development in both academic institutions and industry. As research faculty, first at the University of Michigan and then at UCLA, Dr. Gross studied the role of sleep in memory consolidation. He discovered asynchrony in sleep states, providing insight into the importance of timing of targeted therapies during sleep—such as closed-loop neuromodulation to treat abnormal memory consolidation in PTSD. Dr. Gross also served as VP of R & D for a start-up medical device company, bringing products to market while maintaining FDA compliance. This included the development of novel interfaces for neuroprosthetic and therapeutic devices and a multi-channel non-invasive electrical stimulator for chronic pain, spinal cord injury, and traumatic brain injury patients.